Dr. Hamburg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UCLA Health
120 S Spalding Dr.
Beverly Hills, CA 90212Phone+1 310-205-0771- Is this information wrong?
Summary
- General Hematology, Clotting, Anemia, Myelodysplasia, Myeloproliferative disorders, Acute and chronic leukemia, lymphoma,
Oncology: Lung ca, mesothelioma, GI malignancies, Hepatocellular carcioma, GU malignancies, Breast cancer, Prostate cancer
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1984 - 1987
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1981 - 1984
- New York UniversityMD-PhD, Cell Biology, 1974 - 1981
- New York UniversityPh.D., Basic Medical Sciences, 1973 - 1981
- New York University School of MedicineClass of 1981, MD-PhD, Alpha Omega Alpha
- New York UniversityMaster of Science, Cell Biology, 1976 - 1978
Certifications & Licensure
- CA State Medical License 1984 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Healing Award Tower Cancer Research Foundation, 2013
- Alpha Omega Alpha New York University, 1981
- CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2013
- Join now to see all
Clinical Trials
- Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Start of enrollment: 2006 Oct 23
- Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma Start of enrollment: 2008 Jul 23
- Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease Start of enrollment: 2005 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsSafety and Efficacy of Ruxolitinib in Patients With Myelofibrosis and Low Platelet Counts (50–100 × 109/L): Final Analysis of an Open-label Phase 2 studyMoshe Talpaz, Josef T. Prchal, Lawrence B. Afrin, Murat O. Arcasoy, Solomon I. Hamburg, Jason Clark, Deanna Kornacki, Philomena Colucci, Srdan Verstovsek> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Nov 2
- 15 citationsEvaluation of an alternative ruxolitinib dosing regimen in patients with myelofibrosis: an open-label phase 2 studyMoshe Talpaz, Susan Erickson-Viitanen, Kevin Hou, Solomon I. Hamburg, Maria R. Baer> ;Journal of Hematology & Oncology. 2018 Aug 7
- 11 citationsInterferon-induced enhancement of Fc receptor-mediated macrophage phagocytosis.Rabinovitch M, Hamburg Si, Fleit Hb> ;Journal of the Reticuloendothelial Society. 1980 Dec 1
- Join now to see all
Journal Articles
- Interim analysi8s of safety and efficacy of ruxolitinib in patient with myelofibrosis and low platelet countsTalpaz, M, Paquette, R, Afrin, L, Hamburg, S.I., et. al, J Hematology and Oncology, 1/1/2013
- Heart transplantation using bivalirudin as anticoagulantSimsir SA, Schwarz ER, Czer LS, Hamburg SI, Interact Cardiovasc Thorac Surg, 1/1/2010
- Laparoscopic splenectomy for hairy cell leukemia in pregnancyAdeniji BA, Fallas M, Incerpi M, Hamburg S, Datz R, Ogunyemi D, Case Report Med, 1/1/2010
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Abstract LB-289: A phase I dose escalation study of TKM-080301, a RNAi therapeutic directed against PLK1, in patients with advanced solid tumors.Ramesh K. Ramanathan, Solomon I. Hamburg, Mitesh J. Borad, Mahesh Seetharam, Madappa N. Kundranda, Peter Lee, Paul Fredlund, Mark Gilbert, Cathy Mast, Sean C. Semple, ..., AACR, 1/15/2013
- Preliminary Safety and Efficacy from a Phase II study of Ruxolitinib in Patients with Primary and Secondary Myelofibrosis with Platelet Counts of 50-100x109/L.Moshe Talpaz, Solomon I. Hamburg, Ktarzyna Jamieson, Howard R. Terebelo, Lawrence Afrin, Elliott F. Winton, Michael A. Scola, Roger M. Lyons, Jimmie Huling Harvey Jr.,..., ASCO, 1/1/2012
- Results of a phase 1 dose-escalation study of once-weekly MLN9708, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma.Sarit E. Assouline, Julie Chang, Bruce D. Cheson, Robert Rifkin, Solomon Hamburg, Ruben Reyes, Ai-Min Hui, Jiang Yu, Neeraj Gupta, Alessandra Di Bacco, Yaping Shou, P..., ASCO, 1/1/2012
- Join now to see all
Lectures
- Update in Therapy for P. Vera and MyelofibrosisCedars-Sinai Medical Center, Los Angeles, CA - 1/15/2016
- Myelofibrosis 2014Cedars-Sinai Medical Center, Los Angeles, CA - 1/26/2014
- The Big Spleen: New diagnostic and management considerations. Myeloproliferative disorders.Marina Del Rey, CA - 1/21/2012
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Hospital Affiliations
- Cedars-Sinai Medical CenterLos Angeles, California
- Ronald Reagan UCLA Medical CenterLos Angeles, California
- UCLA Medical Center-Santa MonicaSanta Monica, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: